title: A review of vitamin K, epilepsy and pregnancy.
abstract: Based on a case history of fetal haemorrhage due to maternal antiepileptic treatment and a review of 40 previously described similar cases, it is recommended that epileptic mothers receive vitamin K tablets throughout the month before delivery and intravenously during labour. It is further recommended that phytomenadione should be administered intravenously to the infant immediately after birth. Cord blood specimens should be submitted for immediate clotting studies and if diminished vitamin K-dependent factors are found, fresh frozen plasma should be given at a dose of 20 ml/kg over a period of 1-2 h. Alternatively, the drug treatment of women with epilepsy during pregnancy could be changed from liver enzyme inducing drugs to clonazepam, which is a benzodiazepine without liver enzyme-inducing properties. Further, no malformations have been reported in connection with this drug.
authors.affiliation: University Neurology Clinic, Hvidovre Hospital, Copenhagen, Denmark.
authors.forename: U
authors.initials: U
authors.lastname: Moslet
authors.forename: E S
authors.initials: ES
authors.lastname: Hansen
mesh_terms: D000328:Adult; D001780:Blood Coagulation Tests; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D017029:Epilepsy, Complex Partial / Q000097:blood / Q000188:drug therapy; D004829:Epilepsy, Generalized / Q000097:blood / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000188:drug therapy*; D014812:Vitamin K / Q000008:administration & dosage*
chemical_list: D014812:Vitamin K